{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:30:29Z","timestamp":1788420629395,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5U01AI151788-02"],"award-info":[{"award-number":["5U01AI151788-02"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5U01AI151788-02"],"award-info":[{"award-number":["5U01AI151788-02"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004421","name":"World Bank Group","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/100004421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004421","name":"World Bank Group","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/100004421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As many studies have shown conflicting results regarding the extent of viraemia and clinical disease severity, we sought to investigate if viraemia during early dengue illness is associated with subsequent clinical disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Realtime PCR was carried out to identify the dengue virus (DENV serotype), in 362 patients, presenting within the first 4 days of illness, from 2017 to 2022, in Colombo Sri Lanka. To characterize subsequent clinical disease severity, all patients were followed throughout their illness daily and disease severity classified according to WHO 1997 and 2009 disease classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      263 patients had DF, 99 progressed to develop DHF, and 15\/99 with DHF developed shock (DSS). Although the viral loads were higher in the febrile phase in patients who progressed to develop DHF than in patients with DF this was not significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.5). Significant differences were observed in viral loads in patients infected with different DENV serotypes (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0009), with lowest viral loads detected in DENV2 and the highest viral loads in DENV3. Sub-analysis for association of viraemia with disease severity for each DENV serotype was again not significant. Although those infected with DENV2 had lower viral loads, infection with DENV2 was significantly associated with a higher risk of developing DHF (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011, Odds ratio 1.9; 95% CI 1.164 to 3.078). Based on the WHO 2009 disease classification, 233 had dengue with warning signs (DWW), 114 dengue without warning signs (DWoWS), and 15 had severe dengue (SD). No significant difference was observed in the viral loads between those with SD, DWW and DWoWS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.27).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Viral loads were significantly different in the febrile phase between different DENV serotypes, and do not appear to significantly associate with subsequent clinical disease severity in a large Sri Lankan cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-024-10152-2","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:02:52Z","timestamp":1730800972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Are viral loads in the febrile phase a predictive factor of dengue disease severity?"],"prefix":"10.1186","volume":"24","author":[{"given":"Shashika","family":"Dayarathna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heshan","family":"Kuruppu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tehani","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laksiri","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. L. Ajantha","family":"Shyamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandima","family":"Jeewandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinuka","family":"Ariyaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyrar Tanussiya","family":"Ramu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda","family":"Wijewickrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham S.","family":"Ogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gathsaurie Neelika","family":"Malavige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"10152_CR1","unstructured":"WHO. Ten threats to global health in 2019. In.: World Health Organization; 2019."},{"issue":"7","key":"10152_CR2","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1016\/S2542-5196(21)00132-7","volume":"5","author":"FJ Colon-Gonzalez","year":"2021","unstructured":"Colon-Gonzalez FJ, Sewe MO, Tompkins AM, Sjodin H, Casallas A, Rocklov J, et al. Projecting the risk of mosquito-borne diseases in a warmer and more populated world: a multi-model, multi-scenario intercomparison modelling study. Lancet Planet Health. 2021;5(7):e404\u201314. https:\/\/doi.org\/10.1016\/S2542-5196(21)00132-7.","journal-title":"Lancet Planet Health"},{"key":"10152_CR3","volume-title":"Comprehensive guidelines for prevention and control of dengue fever and dengue haemorrhagic fever","author":"WHO","year":"2011","unstructured":"WHO. Comprehensive guidelines for prevention and control of dengue fever and dengue haemorrhagic fever. SEARO Technical Publication Series. Volume 60. New Delhi, India: World Health Organization;: SEARO; 2011."},{"issue":"1","key":"10152_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12929-022-00833-y","volume":"29","author":"GN Malavige","year":"2022","unstructured":"Malavige GN, Jeewandara C, Ogg GS. Dengue and COVID-19: two sides of the same coin. J Biomed Sci. 2022;29(1):48. https:\/\/doi.org\/10.1186\/s12929-022-00833-y.","journal-title":"J Biomed Sci"},{"issue":"1","key":"10152_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4269\/ajtmh.20-1163","volume":"105","author":"AE Macias","year":"2021","unstructured":"Macias AE, Werneck GL, Castro R, Mascarenas C, Coudeville L, Morley D, et al. Mortality among hospitalized dengue patients with comorbidities in Mexico, Brazil, and Colombia. Am J Trop Med Hyg. 2021;105(1):102\u20139. https:\/\/doi.org\/10.4269\/ajtmh.20-1163.","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"10152_CR6","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S1473-3099(20)30601-0","volume":"21","author":"S Sangkaew","year":"2021","unstructured":"Sangkaew S, Ming D, Boonyasiri A, Honeyford K, Kalayanarooj S, Yacoub S, et al. Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(7):1014\u201326. https:\/\/doi.org\/10.1016\/S1473-3099(20)30601-0.","journal-title":"Lancet Infect Dis"},{"key":"10152_CR7","doi-asserted-by":"publisher","first-page":"590004","DOI":"10.3389\/fcimb.2020.590004","volume":"10","author":"GN Malavige","year":"2020","unstructured":"Malavige GN, Jeewandara C, Ogg GS. Dysfunctional Innate Immune responses and severe dengue. Front Cell Infect Microbiol. 2020;10:590004. https:\/\/doi.org\/10.3389\/fcimb.2020.590004.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10152_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41577-019-0123-x","volume":"19","author":"AL St John","year":"2019","unstructured":"St John AL, Rathore APS. Adaptive immune responses to primary and secondary dengue virus infections. Nat Rev Immunol. 2019;19(4):218\u201330. https:\/\/doi.org\/10.1038\/s41577-019-0123-x.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10152_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00284-020-02284-w","volume":"78","author":"P Bhatt","year":"2021","unstructured":"Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current understanding of the pathogenesis of Dengue Virus infection. Curr Microbiol. 2021;78(1):17\u201332. https:\/\/doi.org\/10.1007\/s00284-020-02284-w.","journal-title":"Curr Microbiol"},{"key":"10152_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coviro.2020.07.009","volume":"43","author":"B Troost","year":"2020","unstructured":"Troost B, Smit JM. Recent advances in antiviral drug development towards dengue virus. Curr Opin Virol. 2020;43:9\u201321. https:\/\/doi.org\/10.1016\/j.coviro.2020.07.009.","journal-title":"Curr Opin Virol"},{"issue":"12","key":"10152_CR11","doi-asserted-by":"publisher","first-page":"e1074","DOI":"10.1093\/cid\/ciaa1840","volume":"72","author":"NL Vuong","year":"2021","unstructured":"Vuong NL, Quyen NTH, Tien NTH, Tuan NM, Kien DTH, Lam PK, et al. Higher plasma viremia in the Febrile phase is Associated with adverse dengue outcomes irrespective of infecting serotype or host Immune Status: an analysis of 5642 Vietnamese cases. Clin Infect Dis. 2021;72(12):e1074\u201383. https:\/\/doi.org\/10.1093\/cid\/ciaa1840.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10152_CR12","doi-asserted-by":"publisher","first-page":"e1309","DOI":"10.1371\/journal.pntd.0001309","volume":"5","author":"V Tricou","year":"2011","unstructured":"Tricou V, Minh NN, Farrar J, Tran HT, Simmons CP. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl Trop Dis. 2011;5(9):e1309. https:\/\/doi.org\/10.1371\/journal.pntd.0001309.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10152_CR13","doi-asserted-by":"publisher","first-page":"e0285087","DOI":"10.1371\/journal.pone.0285087","volume":"18","author":"L Nainggolan","year":"2023","unstructured":"Nainggolan L, Dewi BE, Hakiki A, Pranata AJ, Sudiro TM, Martina B, et al. Association of viral kinetics, infection history, NS1 protein with plasma leakage among Indonesian dengue infected patients. PLoS ONE. 2023;18(5):e0285087. https:\/\/doi.org\/10.1371\/journal.pone.0285087.","journal-title":"PLoS ONE"},{"issue":"3","key":"10152_CR14","doi-asserted-by":"publisher","first-page":"e0004497","DOI":"10.1371\/journal.pntd.0004497","volume":"10","author":"M Singla","year":"2016","unstructured":"Singla M, Kar M, Sethi T, Kabra SK, Lodha R, Chandele A, et al. Immune Response to Dengue Virus infection in Pediatric patients in New Delhi, India\u2013Association of Viremia, Inflammatory mediators and monocytes with Disease Severity. PLoS Negl Trop Dis. 2016;10(3):e0004497. https:\/\/doi.org\/10.1371\/journal.pntd.0004497.","journal-title":"PLoS Negl Trop Dis"},{"key":"10152_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actatropica.2016.12.011","volume":"167","author":"F Perdomo-Celis","year":"2017","unstructured":"Perdomo-Celis F, Salgado DM, Narvaez CF. Magnitude of viremia, antigenemia and infection of circulating monocytes in children with mild and severe dengue. Acta Trop. 2017;167:1\u20138. https:\/\/doi.org\/10.1016\/j.actatropica.2016.12.011.","journal-title":"Acta Trop"},{"issue":"2","key":"10152_CR16","doi-asserted-by":"publisher","first-page":"e0245926","DOI":"10.1371\/journal.pone.0245926","volume":"16","author":"T Silva","year":"2021","unstructured":"Silva T, Jeewandara C, Gomes L, Gangani C, Mahapatuna SD, Pathmanathan T, et al. Urinary leukotrienes and histamine in patients with varying severity of acute dengue. PLoS ONE. 2021;16(2):e0245926. https:\/\/doi.org\/10.1371\/journal.pone.0245926.","journal-title":"PLoS ONE"},{"key":"10152_CR17","unstructured":"WHO. Dengue guidelines, for diagnosis, treatment, prevention and control. In. Edited by (TDR) AjpotWHOWatSPfRaTiTD; 2009."},{"key":"10152_CR18","volume-title":"National guidelines","author":"Ministry of Health SL","year":"2012","unstructured":"Ministry of Health SL. Guidelines on management of dengue fever and dengue haemorrhagic fever in adults. National guidelines. Sri Lanka: Ministry of Health; 2012."},{"issue":"11","key":"10152_CR19","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/infdis\/jiz618","volume":"221","author":"JJ Waggoner","year":"2020","unstructured":"Waggoner JJ, Katzelnick LC, Burger-Calderon R, Gallini J, Moore RH, Kuan G, et al. Antibody-dependent enhancement of severe disease is mediated by serum viral load in Pediatric Dengue Virus infections. J Infect Dis. 2020;221(11):1846\u201354. https:\/\/doi.org\/10.1093\/infdis\/jiz618.","journal-title":"J Infect Dis"},{"issue":"11","key":"10152_CR20","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.jiph.2021.10.002","volume":"14","author":"B Pathak","year":"2021","unstructured":"Pathak B, Chakravarty A, Krishnan A. High viral load positively correlates with thrombocytopenia and elevated haematocrit in dengue infected paediatric patients. J Infect Public Health. 2021;14(11):1701\u20137. https:\/\/doi.org\/10.1016\/j.jiph.2021.10.002.","journal-title":"J Infect Public Health"},{"key":"10152_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12879-016-1668-y","volume":"16","author":"CR Vicente","year":"2016","unstructured":"Vicente CR, Herbinger KH, Froschl G, Malta Romano C, de Souza Areias Cabidelle A, Cerutti Junior C. Serotype influences on dengue severity: a cross-sectional study on 485 confirmed dengue cases in Vitoria, Brazil. BMC Infect Dis. 2016;16:320. https:\/\/doi.org\/10.1186\/s12879-016-1668-y.","journal-title":"BMC Infect Dis"},{"key":"10152_CR22","doi-asserted-by":"publisher","first-page":"104304","DOI":"10.1016\/j.jcv.2020.104304","volume":"125","author":"MM Ngwe Tun","year":"2020","unstructured":"Ngwe Tun MM, Muthugala R, Nabeshima T, Rajamanthri L, Jayawardana D, Attanayake S, et al. Unusual, neurological and severe dengue manifestations during the outbreak in Sri Lanka, 2017. J Clin Virol. 2020;125:104304. https:\/\/doi.org\/10.1016\/j.jcv.2020.104304.","journal-title":"J Clin Virol"},{"key":"10152_CR23","doi-asserted-by":"publisher","unstructured":"Chan KWK, Watanabe S, Jin JY, Pompon J, Teng D, Alonso S, et al. A T164S mutation in the dengue virus NS1 protein is associated with greater disease severity in mice. Sci Transl Med. 2019;11(498). https:\/\/doi.org\/10.1126\/scitranslmed.aat7726.","DOI":"10.1126\/scitranslmed.aat7726"},{"issue":"3","key":"10152_CR24","doi-asserted-by":"publisher","first-page":"e0003468","DOI":"10.1371\/journal.pntd.0003468","volume":"9","author":"FA Medina","year":"2015","unstructured":"Medina FA, Torres-Malave G, Chase AJ, Santiago GA, Medina JF, Santiago LM, et al. Differences in type I interferon signaling antagonism by dengue viruses in human and non-human primate cell lines. PLoS Negl Trop Dis. 2015;9(3):e0003468. https:\/\/doi.org\/10.1371\/journal.pntd.0003468.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10152_CR25","doi-asserted-by":"publisher","first-page":"e1005194","DOI":"10.1371\/journal.pcbi.1005194","volume":"12","author":"R Ben-Shachar","year":"2016","unstructured":"Ben-Shachar R, Schmidler S, Koelle K. Drivers of inter-individual variation in Dengue viral load Dynamics. PLoS Comput Biol. 2016;12(11):e1005194. https:\/\/doi.org\/10.1371\/journal.pcbi.1005194.","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"10152_CR26","doi-asserted-by":"publisher","first-page":"e0011104","DOI":"10.1371\/journal.pntd.0011104","volume":"17","author":"SF Riswari","year":"2023","unstructured":"Riswari SF, Velies DS, Lukman N, Jaya UA, Djauhari H, Ma\u2019roef CN, et al. Dengue incidence and length of viremia by RT-PCR in a prospective observational community contact cluster study from 2005\u20132009 in Indonesia. PLoS Negl Trop Dis. 2023;17(2):e0011104. https:\/\/doi.org\/10.1371\/journal.pntd.0011104.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10152_CR27","doi-asserted-by":"publisher","first-page":"e0004851","DOI":"10.1371\/journal.pntd.0004851","volume":"10","author":"C Sung","year":"2016","unstructured":"Sung C, Wei Y, Watanabe S, Lee HS, Khoo YM, Fan L, et al. Extended evaluation of Virological, Immunological and Pharmacokinetic endpoints of CELADEN: a Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever patients. PLoS Negl Trop Dis. 2016;10(8):e0004851. https:\/\/doi.org\/10.1371\/journal.pntd.0004851.","journal-title":"PLoS Negl Trop Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10152-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10152-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10152-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:05:52Z","timestamp":1730801152000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10152-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10152"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10152-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.07.31.23293412","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-4771323\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"20 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethics Review Committee of the Faculty of Medical Sciences, University of Sri Jayewardenepura (58\/19).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1248"}}